Concomitant antiplatelet or anticoagulant use 
Calculated creatinine clearance < 30 mL/min by Cockcroft-Gault formula 
Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 3 times upper limit of normal (ULN) 
Total bilirubin > 2 x ULN 
Thrombocytopenia < 50 x 10 gigalitres (Gl) 
High bleeding risk or spontaneously prolonged prothrombin time or activated partial thromboplastin time > 1.5 x ULN 
Body weight <50 or >120 kg 
Concomitant use of CYP3A4 or p-glycoprotein inducers or inhibitors 
Use of Ginkgo biloba or St. John's Wort within 14 days before first dose of study drug 
Dexamethasone use within last 3 months 
Women of Childbearing potential without proper contraceptive measures, pregnancy or breast feeding 
Life expectancy less than 3 months 
Inability to swallow or issues with malabsorption 
Any other medical, social, logistical, geographical or psychological factors, which in the opinion of the investigator, would prohibit follow-up, compliance and study completion       
    
